| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.37B | +9.0% |
| Cost of Revenue | $4.60B | +7.4% |
| Gross Profit | $1.77B | +13.1% |
| R&D Expense | $111.0M | +29.1% |
| SG&A Expense | $974.0M | +6.3% |
| Operating Income | $611.0M | +9.3% |
| Pre-tax Income | $418.0M | +18.4% |
| Income Tax | $135.0M | +21.6% |
| Net Income | $283.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $326.0M | -58.2% |
| Accounts Receivable | $1.00B | +14.4% |
| Inventory | $975.0M | +31.8% |
| Current Assets | $2.50B | -1.5% |
| Total Assets | $6.39B | +9.1% |
| Current Liabilities | $1.55B | +3.5% |
| Long-term Debt | $1.43B | +16.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $152.0M | -51.7% |
| Capital Expenditures | $85.0M | +34.9% |
| Investing Cash Flow | -$764.0M | -1075.4% |
| Financing Cash Flow | $170.0M | +750.0% |
| Free Cash Flow | $67.0M | -73.4% |
| +16.9% |
| EPS (Basic) | $1.94 | +15.5% |
| EPS (Diluted) | $1.90 | +16.6% |
| Total Liabilities |
| $3.86B |
| +7.1% |
| Stockholders' Equity | $2.53B | +12.3% |